New Vernon Capital Holdings II’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,601
Closed -$22.4K 82
2023
Q4
$22.4K Sell
1,601
-25,537
-94% -$355K 0.01% 75
2023
Q3
$401K Buy
27,138
+1,020
+4% +$14.3K 0.35% 29
2023
Q2
$337K Buy
26,118
+4,331
+20% +$49.3K 0.23% 29
2023
Q1
$214K Buy
21,787
+169
+0.8% +$1.8K 0.16% 48
2022
Q4
$230K Buy
21,618
+3,418
+19% +$39.7K 0.19% 40
2022
Q3
$190K Sell
18,200
-12,951
-42% -$169K 0.2% 27
2022
Q2
$392K Buy
+31,151
New +$331K 0.32% 15

Other funds holding DVAX

New Vernon Capital Holdings II's DVAX Position: Q1 2024 in Review

New Vernon Capital Holdings II sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 1,601 shares — an estimated $22.4K sold.

New Vernon Capital Holdings II first reported a position in DVAX in Q2 2022 and held it in 7 quarters. The position peaked at $401K in Q3 2023. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • New Vernon Capital Holdings II reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 1,601 Dynavax Technologies shares in Q1 2024, an estimated $22.4K.
  • New Vernon Capital Holdings II first reported a position in Dynavax Technologies in Q2 2022 and held it in 7 quarters.
  • New Vernon Capital Holdings II's Dynavax Technologies position peaked at $401K in Q3 2023.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2024, filed 15 May 2024.